Anti-RNA polymerase II antibodies in a US cohort of systemic sclerosis patients: Comment on the Article by Hamaguchi et al

Arthritis and Rheumatology

Volumn 67, Issue 9, 2015, Pages 2547-2548

  Patel, Veena ^a   Assassi, Shervin ^a   Mayes, Maureen D ^a   Feghali Bostwick, Carol A ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA ANTIBODY; RNA POLYMERASE I ANTIBODY; RNA POLYMERASE II ANTIBODY; RNA POLYMERASE III ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; DNA DIRECTED RNA POLYMERASE III;

CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; LETTER; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; BLOOD; FEMALE; IMMUNOLOGY; MALE;

AUTOANTIBODIES; FEMALE; HUMANS; MALE; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC;

EID: 84940102336     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39203     Document Type: Letter

References (0)